Related Experiment Video
Updated: Aug 11, 2026
11:17
Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Published on: January 7, 2016
Is growth hormone a radioprotective agent?
S B Tekin1, M V Ertekin, F Erdogan
1Department of Medical Oncology, University Faculty of Medicine, Erzurum, Turkey.
Summary
Growth hormone (GH) significantly reduced radiation-induced skin injury in rats, mitigating dermatitis and tissue damage. These findings suggest GH
Area of Science:
- Radiation oncology
- Endocrinology
- Dermatology
Background:
- Radiation therapy can cause normal tissue injury, particularly skin damage.
- Growth hormone (GH) is being investigated for its potential radioprotective properties.
Purpose of the Study:
- To evaluate the efficacy of growth hormone (GH) in preventing radiation-induced skin injury in a rat model.
- To assess the impact of different GH dosages on acute radiation dermatitis.
Main Methods:
- A rat model was used with a single 30 Gy gamma irradiation dose to the hind legs.
- Rats received either no GH, or 0.01 U/kg/day or 0.02 U/kg/day of GH subcutaneously.
- Acute skin reactions were assessed clinically and histopathologically.
Main Results:
- Irradiation significantly increased dermatitis compared to controls.
- GH treatment (0.01 and 0.02 U/kg/day) significantly reduced the severity of radiodermatitis.
- Radiodermatitis developed earlier in the irradiated group without GH.
- GH prevented epidermal atrophy, dermal degeneration (edema, collagen loss), and hair follicle atrophy.
Conclusions:
- Growth hormone demonstrates efficacy in preventing and reducing acute radiation-induced skin injury in rats.
- GH may be a potential therapeutic agent for mitigating radiation toxicity in cancer patients.
- Further studies with higher GH doses are warranted for clinical application.
Related Concept Videos
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
02:59Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
01:26Cellular Adaptation II: Hypertrophy
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...